UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26
Immuneering Rises on Orphan Drug Designation for Treatment of Pancreatic Cancer
The significant risks in November are undergoing crucial changes.
Less than a month away from the usa presidential election day on November 5th, the market is starting to price in the risks of the election results. Currently, Trump has regained a leading advantage, adding variables to the election. CICC believes that for subsequent assets, the overall bullishness of the election is favorable for US stocks but tariffs are unfavorable for chinese assets; the US dollar is relatively strong, gold is neutral, interest rates are rising; bulk commodities may benefit from expectations of Trump's stimulus.
Sector Update: Health Care Stocks Higher Friday Afternoon
Sector Update: Health Care
Harris, Trump Tied in Battle for Swing States, WSJ Poll Shows -- WSJ
teva pharmaceutical industries agreed to pay a settlement of 0.45 billion US dollars to end a US investigation into rebates.
On October 11th, the US Department of Justice announced that Israeli non-patent pharmaceutical company Teva Pharmaceutical Industries has agreed to pay a $450 million settlement to end an investigation into possible illegal kickback schemes by the company. Brian M. Boynton, Deputy Assistant Attorney General of the US Department of Justice, stated that the pharmaceutical company's practice of offering kickbacks to the industry harms fair market competition and is detrimental to the healthcare policies being implemented in the USA.
Teva Pharmaceuticals to Pay $450M to Settle Kickback Allegations
'Drug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing' - DOJ
Wall Street is "waiting quietly" for the usa election, how will the election trade seize the opportunity?
The USA election is approaching, but Wall Street is surprisingly quiet.
The significant cooling of inflation in the usa, what does it mean for the presidential election?
The retreat of inflation does not mean a decrease in prices. With less than a month left until the usa election, price issues continue to worry voters and become a focal point in the campaign.
usa's 'most controversial' election is approaching, investors are starting to prepare for political risks.
①Investors expect the voting results to be questioned in various ways, potentially the most controversial election in US history; ②UBS Group analyst Kurt Reiman suggested that investors should consider popular safe-haven assets such as utility stocks and gold to hedge against potential political risks.
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...
Who will win, Trump or Harris? The Dow predicts a 92% chance of winning the election.
The performance of the Dow before the election day 11 weeks, is related to whether the ruling party candidate has won the presidential election since 1968.
U.S. Government to Release Preliminary List for Pilot Medicare Program Offering Generics Under $2 - Report
Express News | Teva Pharmaceutical Industries Ltd - FDA and EMA Decisions Expected in 2H 2025
Express News | Teva Prolia® (Denosumab) Biosimilar Candidate Is Accepted for Review by U.S. FDA and EU EMA
Teva Prolia (Denosumab) Biosimilar Candidate Is Accepted for Review by U.S. FDA and EU EMA
US State Of Georgia's Supreme Court Reinstates Abortion Ban That Was Blocked By Lower Court
Teva and MAbxience Expand Strategic Partnership to Include an Additional Oncology Biosimilar Candidate